News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A new treatment for erectile dysfunction (ED) has received regulatory approval in the Kingdom of Saudi Arabia, a key ED market, with 10.45% of married males experiencing the condition.
Ginkgo Bioworks, a platform for cell programming and biosecurity, has announced a new partnership with Boehringer Ingelheim.
Teknova, a producer of life science reagents, has opened a new GMP-certified production facility which it claims will enable bioprocessing and gene therapy companies to get into the clinic faster.